Skip to main content

3 Reasons to Sell CORT and 1 Stock to Buy Instead

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

CORT Cover Image

The past six months have been a windfall for Corcept’s shareholders. The company’s stock price has jumped 201%, hitting $122.93 per share. This was partly due to its solid quarterly results, and the performance may have investors wondering how to approach the situation.

Is now the time to buy Corcept, or should you be careful about including it in your portfolio? Check out our in-depth research report to see what our analysts have to say, it’s free.

Why Is Corcept Not Exciting?

We’re glad investors have benefited from the price increase, but we’re sitting this one out for now. Here are three reasons you should be careful with CORT, plus one stock we’d rather own.

1. EPS Trending Down

Analyzing the long-term change in earnings per share (EPS) shows whether a company’s incremental sales were profitable — for example, revenue could be inflated through excessive spending on advertising and promotions.

Sadly for Corcept, its EPS declined by 16.1% annually over the last five years while its revenue grew by 19.3%. This tells us the company became less profitable on a per-share basis as it expanded.

Corcept Trailing 12-Month EPS (Non-GAAP)

2. Free Cash Flow Margin Dropping

If you’ve followed StockStory for a while, you know we emphasize free cash flow. Why, you ask? We believe that in the end, cash is king, and you can’t use accounting profits to pay the bills.

As you can see below, Corcept’s margin dropped by 25.7 percentage points over the last five years. Continued declines could signal it is in the middle of an investment cycle. Corcept’s free cash flow margin for the trailing 12 months was 12.9%.

Corcept Trailing 12-Month Free Cash Flow Margin

3. New Investments Fail to Bear Fruit as ROIC Declines

We like to invest in businesses with high returns, but the trend in a company’s ROIC can also be an early indicator of future business quality.

Over the last few years, Corcept’s ROIC has unfortunately decreased significantly. We like what management has done in the past, but its declining returns are perhaps a symptom of fewer profitable growth opportunities.

Corcept Trailing 12-Month Return On Invested Capital

Final Judgment

Corcept isn’t a terrible business, but it doesn’t pass our quality test. Following the recent surge, the stock trades at 26× forward P/E (or $122.93 per share). Beauty is in the eye of the beholder, but we don’t really see a big opportunity at the moment. We’re pretty confident there are more exciting stocks to buy at the moment. We’d suggest looking at an all-weather company that owns household favorite Taco Bell.

High-Quality Stocks for All Market Conditions

ALSO WORTH WATCHING: Top 5 Momentum Stocks. The best time to own a great stock is when the market is finally noticing it. These aren’t just high-quality businesses. Something is happening with them right now. Elite fundamentals meet near-term momentum — both boxes checked at the same time.

Find out which stocks our AI platform is flagging this week. See this week’s Strong Momentum stocks — FREE. Get Our Strong Momentum Stocks for Free HERE.

Stocks that have made our list include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+214% between June 2020 and June 2025). Find your next big winner with StockStory today.

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  259.92
+3.63 (1.42%)
AAPL  336.67
+3.04 (0.91%)
AMD  645.86
-3.56 (-0.55%)
BAC  53.52
-0.57 (-1.05%)
GOOG  347.37
+2.78 (0.81%)
META  721.31
-17.57 (-2.38%)
MSFT  529.76
+0.46 (0.09%)
NVDA  237.47
-1.77 (-0.74%)
ORCL  143.56
-1.21 (-0.84%)
TSLA  377.81
-2.87 (-0.75%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.